DJ
NImmune Biopharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| omilancor | Ulcerative Colitis | Phase 3 |
Leadership Team at NImmune Biopharma
DR
Dr. Raquel Hontecillas
Chief Scientific Officer
DA
Dr. Andrew Leber
Chief Development Officer
MC
Marek Ciszewski, JD
Chief Financial Officer
PR
Pamela R. Demain, MBA, CLP
SVP of Business Development
DN
Dr. Nuria Tubau-Juni
VP of Inflammation and Immunology